-
Loading metrics
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction
-
Kei Yamamoto ,
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing
* E-mail: kyamamoto@hosp.ncgm.go.jp
Affiliation Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan
⨯ - Yusuke Ohsiro,
-
Tetsuya Suzuki,
Roles Writing – review & editing
Affiliation Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan
⨯ - Michiyo Suzuki,
- Sayaka Miura,
- Maki Nagashima,
- Noriko Iwamoto,
- Junko S. Takeuchi,
-
Moto Kimura,
Roles Project administration, Writing – review & editing
Affiliation Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan
⨯ - Wataru Sugiura,
- Satoru Nebuya,
- Masato Kurokawa,
- Norio Ohmagari
https://orcid.org/0000-0001-6218-523X
Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction
- Kei Yamamoto,
- Yusuke Ohsiro,
- Tetsuya Suzuki,
- Michiyo Suzuki,
- Sayaka Miura,
- Maki Nagashima,
- Noriko Iwamoto,
- Junko S. Takeuchi,
- Moto Kimura,
- Wataru Sugiura
- Published: March 30, 2023
- https://doi.org/10.1371/journal.pone.0279897